BIOMAT Database Logo BIOMAT Database Logo

Subspecific differentiation of Burkholderia cepacia isolates in cystic fibrosis. 1998

M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Department of Pharmaceutical and Biological Sciences, Aston University, Birmingham, UK.

Thirty clinical isolates of Burkholderia cepacia from cystic fibrosis (CF) patients in the UK and Denmark were characterised, together with other clinical isolates and laboratory strains of B. cepacia, B. gladioli and B. vietnamiensis. Outer-membrane protein (OMP) profiles were determined, and the organisms were typed genotypically by pulsed-field gel electrophoresis after DNA restriction analyses with Xbal and DraI. This latter method revealed four clusters among the clinical isolates studied; one of these contained isolates of the UK and intercontinental CF epidemic lineage ET12, a cluster which appeared to contain three subtypes. Each of the four clusters appeared less closely related to laboratory strains of B. cepacia than were laboratory strains of B. vietnamiensis, but more closely related to both these species than to B. gladioli. Two types of OMP profile were distinguished among the clinical isolates and strains, and were designated A and B. In type A isolates the major proteins had mol.wts of 39, 27 and 18 kDa. Type B strains additionally contained a group of proteins in the size range 80-90 kDa, although detection of these depended upon the conditions for sample denaturation. In most cases, the OMP type correlated with the genotype, suggesting that examination of OMPs might be of value in the initial characterisation of isolates.

UI MeSH Term Description Entries
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D003718 Denmark A country in northern Europe, bordering the Baltic Sea and the North Sea. The capital is Copenhagen. Faeroe Islands,Faroe Islands
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D015183 Restriction Mapping Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA. Endonuclease Mapping, Restriction,Enzyme Mapping, Restriction,Site Mapping, Restriction,Analysis, Restriction Enzyme,Enzyme Analysis, Restriction,Restriction Enzyme Analysis,Analyses, Restriction Enzyme,Endonuclease Mappings, Restriction,Enzyme Analyses, Restriction,Enzyme Mappings, Restriction,Mapping, Restriction,Mapping, Restriction Endonuclease,Mapping, Restriction Enzyme,Mapping, Restriction Site,Mappings, Restriction,Mappings, Restriction Endonuclease,Mappings, Restriction Enzyme,Mappings, Restriction Site,Restriction Endonuclease Mapping,Restriction Endonuclease Mappings,Restriction Enzyme Analyses,Restriction Enzyme Mapping,Restriction Enzyme Mappings,Restriction Mappings,Restriction Site Mapping,Restriction Site Mappings,Site Mappings, Restriction
D016000 Cluster Analysis A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both. Clustering,Analyses, Cluster,Analysis, Cluster,Cluster Analyses,Clusterings
D016521 Electrophoresis, Gel, Pulsed-Field Gel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length. Electrophoresis, Gel, Pulsed-Field Gradient,Gel Electrophoresis, Pulsed-Field,Contour-Clamped Homogeneous-Field Gel Electrophoresis,Electrophoresis, Gel, Pulsed Field,Electrophoresis, Pulsed Field Gel,Field Inversion Gel Electrophoresis,Orthogonal Field Alternation Gel Electrophoresis,Orthogonal-Field Alternation-Gel Electrophoresis,Pulsed Field Gradient Gel Electrophoresis,Pulsed-Field Gel Electrophoresis,Pulsed-Field Gradient Gel Electrophoresis,Alternation-Gel Electrophoresis, Orthogonal-Field,Contour Clamped Homogeneous Field Gel Electrophoresis,Electrophoresis, Orthogonal-Field Alternation-Gel,Electrophoresis, Pulsed-Field Gel,Gel Electrophoresis, Pulsed Field,Pulsed Field Gel Electrophoresis

Related Publications

M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.
February 1998, Infection and immunity,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Burkholderia cepacia in cystic fibrosis.
March 1995, The New England journal of medicine,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Burkholderia cepacia in cystic fibrosis.
March 1995, The New England journal of medicine,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Burkholderia cepacia in cystic fibrosis.
March 1995, The New England journal of medicine,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Burkholderia cepacia infections in cystic fibrosis.
February 1999, The Pediatric infectious disease journal,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis.
May 1994, FEMS immunology and medical microbiology,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.
August 1997, Journal of clinical microbiology,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand.
December 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Burkholderia cepacia--a transmissible cystic fibrosis pathogen.
November 2001, The Journal of pediatrics,
M A Livesley, and I A Baxter, and P A Lambert, and J R Govan, and P H Weller, and D E Lacey, and D G Allison, and B Giwercman, and N Hoiby
Burkholderia cepacia complex in Indian cystic fibrosis patients.
November 2012, The Indian journal of medical research,
Copied contents to your clipboard!